2m 2m 2m 2m 2m 2m 2m
Artivion (AORT)
NYSE
$20.51-$0.18 (-0.85%)
Price as of Jun 23, 2026 5:39 PM EDT- $977.2MMarket Cap
- -34.75%1-Year Change
- Medical DevicesIndustry
Artivion (AORT)
$20.51-$0.18 (-0.85%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 345.8M -10.99% | 388.5M +9.75% | 354.0M +12.82% | 313.8M +5.00% | |
Cost of Revenue | 112.8M -19.30% | 139.8M +11.96% | 124.8M +12.19% | 111.3M +9.81% | |
Gross Profit | 284.2M +14.25% | 248.8M +8.55% | 229.2M +13.16% | 202.5M +2.54% | |
Sales and Marketing Expense | 226.5M +24.82% | 181.5M -13.17% | 209.0M +32.73% | 157.4M -7.26% | |
Research and Development Expense | -31.0M +8.92% | -28.5M -0.89% | -28.7M -26.16% | -38.9M +9.38% | |
Depreciation and Amortization Expense | 22.5M -7.22% | 24.2M +4.89% | 23.1M +2.83% | 22.4M -6.40% | |
Total Operating Expenses | 257.5M +22.66% | 209.9M -11.69% | 237.7M +21.07% | 196.3M -4.38% | |
Operating Profit | 33.7M -13.19% | 38.9M +577.01% | 5.7M -7.40% | 6.2M -23.60% | |
Interest Income | 763,000 -47.99% | 1.5M +36.21% | 1.1M +632.65% | 147,000 +86.08% | |
Interest Expense | -2.1M -58.00% | -5.0M -80.24% | -25.3M +38.82% | -18.2M +7.83% | |
Interest Income and Expense and Net | -1.3M -62.16% | -3.5M -85.41% | -24.2M +33.99% | -18.1M +7.47% | |
Total Nonoperating Income and Expense | 9.5M +196.05% | -9.9M +219.03% | -3.1M -0.06% | -3.1M -49.35% | |
Income before Taxes | 14.8M +296.70% | -7.5M -65.19% | -21.6M +44.06% | -15.0M +1.06% | |
Income Taxes | 5.0M -14.25% | 5.8M -35.80% | 9.1M +116.35% | 4.2M +60,014.29% | |
Extraordinary Items | N/A N/A | N/A N/A | 390,000 N/A | N/A N/A | |
Net Income | 9.8M +173.12% | -13.4M -56.47% | -30.7M +59.91% | -19.2M +29.38% | |
Net Income from Continuing Operations Applicable to Common | 14.8M +296.70% | -7.5M -65.19% | -21.6M +44.06% | -15.0M +1.06% | |
Basic EPS and Net Income | 0.22 +168.75% | -0.32 -57.33% | -0.75 +56.25% | -0.48 +26.32% | |
Diluted EPS and Net Income | 0.21 +165.63% | -0.32 -57.33% | -0.75 +56.25% | -0.48 +26.32% | |
Basic Weighted Average Shares | 45.3M +8.78% | 41.7M +2.29% | 40.7M +1.78% | 40.0M +2.69% | |
Diluted Weighted Average Shares | 47.2M +13.16% | 41.7M +2.29% | 40.7M +1.78% | 40.0M +2.69% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 64.9M +21.41% | 53.5M -9.29% | 58.9M +49.78% | 39.4M -28.47% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 64.9M +21.41% | 53.5M -9.29% | 58.9M +49.78% | 39.4M -28.47% | |
Total Current Assets | 358.1M +23.44% | 290.1M +3.35% | 280.7M +13.48% | 247.3M -0.15% | |
Accumulated Depreciation | N/A N/A | N/A N/A | 84.9M -3.87% | 88.3M +7.54% | |
Property and Plant and Equipment and Net | 65.0M +78.52% | 36.4M -5.10% | 38.4M -0.82% | 38.7M +3.07% | |
Total Long-Term Assets | 15.2M -37.76% | 24.5M +175.28% | 8.9M +21.19% | 7.3M -11.23% | |
Total Assets | 884.8M +12.13% | 789.1M -0.42% | 792.4M +3.88% | 762.8M -3.81% | |
Income Taxes Payable | 31.8M +37.55% | 23.1M -10.02% | 25.7M -5.32% | 27.1M -16.34% | |
Total Short-Term Debt | 0 -100.00% | 195,000 -86.56% | 1.5M -9.76% | 1.6M -1.35% | |
Total Current Liabilities | 101.6M +51.98% | 66.8M +15.49% | 57.9M +16.48% | 49.7M +10.50% | |
Total Long-Term Debt | 215.1M -31.53% | 314.2M +2.82% | 305.5M -0.32% | 306.5M -0.32% | |
Total Long-Term Liabilities | 9.1M +12.92% | 8.1M +9.86% | 7.3M +4.47% | 7.0M +8.37% | |
Total Liabilities | 436.6M -14.88% | 512.9M +0.45% | 510.6M +6.72% | 478.5M -2.81% | |
Retained Earnings | -51.5M -15.94% | -61.3M +27.89% | -47.9M +178.25% | -17.2M -971.75% | |
Total Stockholders Equity | 448.2M +62.29% | 276.2M -1.98% | 281.8M -0.90% | 284.3M -5.45% | |
Total Shares Outstanding | 49.3M +13.58% | 43.4M +2.03% | 42.6M +1.77% | 41.8M +1.05% | |
Cash Flow | |||||
Cash from Operating Activities | 39.9M +79.35% | 22.2M +18.12% | 18.8M +465.32% | -5.2M +99.34% | |
Capital Expenditures | 39.0M +248.95% | 11.2M +50.58% | 7.4M -17.59% | 9.0M -31.13% | |
Cash from Investing Activities | -42.0M +49.15% | -28.2M +5,515.14% | -502,000 -95.31% | -10.7M -289.31% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 11.3M +412.12% | 2.2M +154.68% | 865,000 +152.78% | -1.6M -86.59% | |
Financials Ratio | |||||
Gross Margin | 67.39% +5.24% | 64.03% -1.09% | 64.74% +0.31% | 64.54% -2.35% | |
Operating Margin | 9.76% -2.47% | 10.01% +516.84% | 1.62% -17.92% | 1.98% -27.24% | |
Return on Assets | 1.17% +169.08% | -1.69% -57.20% | -3.95% +59.98% | -2.47% +31.59% | |
Return on Equity | 2.70% +156.32% | -4.79% -55.84% | -10.84% +65.26% | -6.56% +39.19% | |
Revenue Growth | -10.99% -212.69% | 9.76% -23.88% | 12.82% +156.13% | 5.00% -72.22% | |
Current Ratio | 3.53 -18.77% | 4.34 -10.51% | 4.85 -2.58% | 4.98 -9.64% | |
Cash Ratio | 0.64 -20.12% | 0.80 -21.45% | 1.02 +28.58% | 0.79 -35.26% | |
Debt-to-Equity Ratio | 0.48 -57.83% | 1.14 +4.47% | 1.09 +0.54% | 1.08 +5.42% | |
Debt-to-Assets Ratio | 0.24 -38.98% | 0.40 +2.84% | 0.39 -4.09% | 0.40 +3.62% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow